Let’s explore the implications of this clinical achievement for Kodiak’s market position, the calculations behind its current ...
Kodiak Sciences' stock (NASDAQ: KOD) saw a massive 75% breakout yesterday, March 26 2026, pushing the stock to nearly $40 ...
The post-pandemic bubble popped, but life sciences aren’t going anywhere. Blackstone announced Monday that it closed ...
Wave Life Sciences (WVE) stock plunges as the company interim data from an early-stage trial for WVE-007, its RNA-based ...
The U.S. Patent and Trademark Office (USPTO) on Monday held the first of three planned Patent Trial and Appeal Board ...
Shares of Kodiak Sciences shot higher after the company disclosed what it called positive results from a late-stage study of its treatment for diabetic retinopathy, a progressive disease that occurs ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI ("BXLS VI"). BXLS VI was oversubscribed ...
Family and consumer sciences professionals shape lives daily, support communities and quietly power some of the country’s most essential industries. For years, the value of that work has been clear to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results